Renal Cell Carcinoma 

Renal cell carcinoma has an estimated lifetime prevalence of 2.3% for men and 1.3% for women in the US. Affected patients in early stages can have greater than 94% cancer-specific survival. Author William Y. Kim, MD, of the University of North Carolina joins JAMA Associate Editor David L. Simel, MD, MHS, to discuss the epidemiology, clinical presentation, pathophysiology, and management of renal cell carcinoma.
Related Content:
Renal Cell Carcinoma
jamanetwork.co...
Podcast was originally published on August 28, 2024.
edhub.ama-assn...
---------------------------------------------------------------------------------
Follow JAMA Clinical Reviews on:
RU-vid: • JAMA Clinical Reviews
Apple Podcasts: podcasts.apple...
Spotify: open.spotify.c...
Pocket Casts: pca.st/3ghw
Your podcast app of choice: pod.link/10274...
Website: jamanetwork.co...
---------------------------------------------------------------------------------
For more from JAMA
• www.jama.com
• / jamajournal
• / jama_current
• / jamanetwork
Follow the JAMA Network
• www.jamanetwor...
• www.jamanetwork...
• / jamanetwork
• / jamanetwork
• / jamanetwork
• / jamanetwork